重庆山外山血液净化技术股份有限公司

What 重庆山外山血液净化技术股份有限公司 does

Chongqing Shanwaishan Blood Purification Technology Co., Ltd. (重庆山外山血液净化技术股份有限公司, ticker 688410.SH) is a vertically integrated Chinese blood purification medical device company founded in 2001 by Chairman Gao Guangyong and headquartered in Chongqing. The company designs, manufactures, and sells a full industry chain of blood purification equipment and consumables, including the SWS-5000 series continuous blood purification device (CRRT) integrating 14 treatment modes (CRRT, artificial liver, plasma exchange), SWS-4000/6000 series hemodialysis machines with the only domestic NMPA-registered four-monitoring technology (blood pressure, blood volume, blood temperature, clearance rate), and SWS-2000S hemoperfusion machines. Its product portfolio is complemented by an HDIMS IoT-based smart dialysis center management platform and ~10 company-operated chain dialysis centers in Chongqing.

The company operates a hybrid business model combining capital equipment sales, recurring consumables revenue (dialyzers, blood lines, hemoperfusion cartridges, dialysate powder/concentrate), subscription/managed services (HDIMS licensing, chain dialysis centers), and project-based government collaborations. Revenue is generated through direct enterprise sales to top-tier Chinese hospitals (PLA General, East Theater, West China, Qilu, Xiangya, Fudan Zhongshan), regional field sales teams, government/procurement channels (two-ministry CRRT promotion project, 22-province alliance procurement), and an international distributor network spanning 100+ countries with 18-year India partnership longevity. FY2023 Q1-Q3 revenue reached 576M RMB (+122% YoY) with 55.47% gross margin and 182M RMB net profit (+431% YoY).

The company became the first STAR Market listed company from Chongqing in December 2022, raising 1.169 billion RMB, and is constructing a 2 billion RMB / 200,000 sqm Blood Purification Industrial Park expected to deliver ~30 billion RMB annual output value. It is the first STAR Market listed blood purification company in China, holds 200+ authorized patents, drafted 4 national and 6 industry standards, and was awarded the National Science and Technology Progress Award (Second Prize) and 22nd China Patent Silver Award.

Name

重庆山外山血液净化技术股份有限公司

Legal name

重庆山外山血液净化技术股份有限公司

Website

https://swskj.com

Company type

Public

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Chongqing Shanwaishan (688410.SH) is a vertically integrated Chinese blood purification medical device company that designs, manufactures, and sells CRRT machines, hemodialysis machines, hemoperfusion devices, blood purification consumables, smart dialysis management software, and operates chain dialysis centers, serving tertiary hospitals, county-level care, and international markets across 100+ countries.

Ownership category

akta.pro rank

Product category

Blood Purification Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodialysis Machines & Systems (HLAHAKAA)

akta.pro secondary industries

Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges) (HLAHAKAH), Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG)

Keywords

• Blood purification equipment
• Hemodialysis machines
• CRRT devices
• Blood purification consumables
• Dialysis center management

Headquarters

HQ city

Chongqing

HQ country

China

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Blood Purification Equipment Sales: Sales of SWS-5000 Series CRRT, SWS-4000/6000 Series hemodialysis machines, SWS-2000 hemoperfusion machines to hospitals and dialysis centers; one-time capital equipment sales with recurring consumables revenue; international sales via distributor network
2. Blood Purification Consumables: Sales of dialyzers (SD series), blood lines, hemoperfusion cartridges (TN series), dialysate filters, dialysate powder/concentrate, CRRT管路; recurring consumable revenue tied to installed equipment base; subsidiary Tianwaiwai and Delaifu produce consumables
3. Chain Dialysis Center Services: Operation of ~10 chain dialysis centers in Chongqing providing dialysis treatment services to end-stage renal disease patients; monthly per-session revenue model; strategic channel for product validation and market expansion
4. Dialysis Center Smart Management System (HDIMS) Software/SaaS: Licensing and deployment of HDIMS software to hospital dialysis centers; remote operation and maintenance services; software customization and integration with hospital information systems
5. Project-based Government Collaborations: Participating in government-funded research projects (National Key R&D Program, two-ministry CRRT promotion projects); revenue from technology transfer and collaborative development with top-tier hospitals (Zhongshan Hospital, Shanghai 6th People's Hospital)

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Chongqing Shanwaishan designs, manufactures and sells a full industry chain of blood purification medical devices and consumables, including CRRT equipment (SWS-5000 series), hemodialysis machines (SWS-4000/6000), blood perfusion machines (SWS-2000S), polyethersulfone dialyzers (SD series), hemoperfusion cartridges (TN series), dialysate filters, dialysis tubing, and dialysate powder/concentrate. It also provides the HDIMS intelligent dialysis center management platform and operates chain dialysis centers in Chongqing. Products are sold to hospitals, dialysis centers and healthcare systems in China and 100+ countries.

Product overview

重庆山外山血液净化技术股份有限公司 operates as a vertically integrated blood purification solutions provider, offering a full industry chain comprising blood purification equipment (SWS-5000 series CRRT, SWS-4000/SWS-6000 hemodialysis machines, SWS-2000S blood灌流机), blood purification耗材 (dialyzers,灌流器, dialysate filters, tubing, dialysate powder/concentrate under brands 德莱福 and 天外天), the HDIMS intelligent dialysis center management platform, and chain dialysis center services. The equipment portfolio and耗材 are designed to interoperate within a unified ecosystem, enabling end-to-end management from device operation through耗材 supply and center operations, all supported by remote O&M and big data infrastructure.

Differentiator

Problem solved

Functional benefit

Brands

• SWS系列: Blood purification equipment product line including SWS-5000, SWS-4000, SWS-6000 series blood purification machines
• TN系列
• SD系列/德莱福
• 天外天
• HDIMS

Quantifiable outcome

• CRRT equipment market share ranked #1 in China for 3 consecutive years (2023-2025)
• +6 more outcomes

Named customers11 records

Segments5 records

Ideal customer profiles4 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• 复旦大学附属中山医院 (Fudan University Zhongshan Hospital)coreStrategic or Co-development Partner · 2 December 2025Leading hospital and co-lead unit of the two-ministry CRRT promotion project; jointly promoting SWS-5000 CRRT in 100+ hospitals nationwide; leading expert Prof. Hu Jiachang presenting project implementation plan; 2025 Shanghai Medical Science Award nomination (collaborating on acute kidney injury research)
• 两部委CRRT推广应用项目联合体医院 (8 additional hospitals)coreStrategic or Co-development Partner · 2 December 20258 hospitals forming '1+1+N' medical-engineering consortium with Shanwaishan and Zhongshan Hospital: Shanghai Sixth People's Hospital, Nanchang University First Affiliated Hospital, Wuhan University Zhongnan Hospital, Anhui Medical University Second Affiliated Hospital, Chengdu Medical College First Affiliated Hospital, Xiamen University First Affiliated Hospital, Shenzhen People's Hospital, Lishui People's Hospital
• 白俄罗斯共和国 (Belarus Government)minorStrategic or Co-development Partner · 14 March 2025Belarus Embassy Minister Counselor Alexander Podkovyrov visited company exploring blood purification equipment and consumables cooperation; Belarus Ministry of Health's National Medical Practice Center showed strong interest; potential to build dialysis centers in Belarus as Belt & Road cooperation
• 重庆大学 (Chongqing University)minorStrategic or Co-development Partner · 31 October 2024
• 中华人民共和国商务部 (MOFCOM International Training Program)minorGTM or Marketing Partner · 19 June 2024MOFCOM-organized training program for 32 officials from 9 developing countries (Ethiopia, Nigeria, Costa Rica, Zimbabwe, Rwanda, Nepal, Uzbekistan, Uganda, Laos) visited company; part of Belt and Road international cooperation; officials from health ministries and medical institutions learned about Shanwaishan products
• 中国医疗器械行业协会血液净化专业委员会coreStrategic or Co-development Partner · 23 December 2023Shanwaishan as secretariat unit; company COO Peng Yanfang elected as first secretary-general; company played key role in establishing the only national-level blood purification industry organization under China Association for Medical Devices;汪年松 (Shanghai Sixth People's Hospital) elected as committee chairman; company hosts academic annual meetings and provides industry platform
• RenalCan Inc. (Canada)minorStrategic or Co-development Partner · 9 June 2019Partnership with Canadian peritoneal dialysis specialist founded by Dr. George Wu and Dr. Paul Tam (leading Canadian nephrology experts); focuses on peritoneal dialysis machine and solution R&D; provides international expert support for Shanwaishan's chain dialysis centers; Dr. Wu became honorary expert for Shanwaishan dialysis centers; arranged training opportunities in Canadian dialysis centers
• India Distributor (V. Venkatesh Company)coreChannel Partner/ Reseller/ Distributor · 1 January 200618-year partnership since first export to India in 2006; two SWS-4000A hemodialysis machines sold initially; partnership evolved to cover hundreds of hospitals in India; 2024 added 200+ new installations in Russia; representative of long-term international distributor model

Scale indicators10 records

Recent moves11 records

Expansion highlights5 records

Broad incumbents

• DaVita: World's largest dialysis services operator with integrated equipment and pharmacy. Comparable to Shanwaishan's chain dialysis center business model; large-scale ESRD patient management expertise informs potential partnership or competitive overlap.
• WEGO Group (Weigao Group): Large Chinese medical device conglomerate with a dialysis product line including HD machines and consumables. Broader portfolio competitor in domestic hospital tenders; directly competes on Chinese procurement contracts.

Direct peers

• Baxter International: Major manufacturer of CRRT systems (e.g., Prismax), hemodialysis machines, and PD solutions. Directly comparable in critical-care blood purification equipment and consumables, especially across emerging markets where Baxter holds strong share.
• Toray Medical: Japanese manufacturer of polysulfone hollow-fiber dialyzers (Filtryzer) and other blood purification products. Direct comparable in high-performance dialyzer technology; competes globally especially in Asia and Middle East.
• B. Braun: German medical device conglomerate with a substantial dialysis division (Dialog+, hemodiafiltration systems, dialyzers). Closely comparable in HD equipment and consumables, and a key competitor in Europe, Middle East, and Southeast Asia where Shanwaishan is expanding.
• Jafron Biomedical: Leading Chinese hemoperfusion cartridge manufacturer listed on Shenzhen Stock Exchange. Most direct domestic competitor in disposable blood purification consumables; competes with Tianwaitian in hemoperfusion cartridges and shares Shanwaishan's hospital channel.
• Asahi Kasei Medical: Japanese manufacturer of hollow-fiber dialyzers using advanced PES membrane technology. Direct comparable in high-end dialyzer consumables; competes with Delaifu in steam-sterilized dialyzer segment.
• Fresenius Medical Care: Global dialysis market leader providing hemodialysis machines, CRRT devices, dialyzers, and dialysis services through Fresenius Kidney Care. Most direct global comparable to Shanwaishan's equipment + consumables + services stack; competing head-to-head in international tenders.
• Nipro Corporation: Japanese medical device company with a large dialysis products business (dialyzers, dialysis machines, PD systems). Direct competitor in dialyzer manufacturing and HD equipment, particularly across Asia-Pacific and Belt & Road markets.

Emerging players

• Outset Medical: US-based maker of the Tablo hemodialysis system with cloud-connected data platform for hospitals and home dialysis. Comparable to Shanwaishan in combining equipment + HDIMS-style smart management + multi-setting deployment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E9%87%8D%E5%BA%86%E5%B1%B1%E5%A4%96%E5%B1%B1%E8%A1%80%E6%B6%B2%E5%87%80%E5%8C%96%E6%8A%80%E6%9C%AF%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 重庆山外山血液净化技术股份有限公司